Search

Search Constraints

You searched for: Author/Creator Congreve, Miles

Search Results

1. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease. Issue 1 (23rd February 2022)

5. Crystal Structure of Human Soluble Adenylate Cyclase Reveals a Distinct, Highly Flexible Allosteric Bicarbonate Binding Pocket. Issue 4 (24th February 2014)

6. Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties1. Issue 5 (13th May 2015)

7. First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1‐receptor partial agonist for the treatment of dementias. Issue 7 (5th February 2021)

8. Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug design. Issue 20 (15th October 2019)

9. Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure-based drug design. Issue 20 (15th October 2019)

10. Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1‐acetylcholine receptor agonist: A randomized cross‐over trial. Issue 11 (8th May 2021)